Metformin Toxicity Masquerading As Acute Abdomen: A Clinical Reminder of Metformin-Associated Lactic Acidosis and Its Management
Abstract
Metformin is commonly used to manage type 2 diabetes mellitus (T2DM), but it is linked to a rare yet potentially life-threatening complication known as metformin-associated lactic acidosis (MALA). MALA typically occurs in patients with renal impairment, but may also be seen in those with liver disease, heart failure, or other metabolic disturbances. Management is primarily supportive, with aggressive interventions including decontamination and extracorporeal treatments such as continuous renal replacement therapy (CRRT) to reverse acidosis and clear metformin metabolites. A 72-year-old female with T2DM on metformin presented with severe diffuse abdominal pain, lethargy, and severe metabolic acidosis following a colonoscopy five days earlier, which was complicated by dehydration. Imaging ruled out pneumoperitoneum, and exploratory laparotomy revealed no ischemia or perforation. With suspicion of metformin toxicity, the patient was promptly started on CRRT, leading to rapid improvement. A metformin level confirmed the diagnosis of metformin toxicity. Although MALA is rare, it is critical to maintain a high index of suspicion in diabetic patients, particularly those with renal impairment or undergoing procedures that may exacerbate kidney injury. Early identification and initiation of extracorporeal treatment are crucial in managing severe metabolic acidosis and improving patient outcomes. This case underscores the importance of careful monitoring and management in diabetic…
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Metformin as an adjuvant in breast cancer treatment
- Metformin Lysosomal Targeting: A Novel Aspect to Be Investigated for Metformin Repurposing in Neurodegenerative Diseases?
- Aberrant HSF1 signaling activation underlies metformin amelioration of myocardial infarction in mice
- Metformin induces ZFP36 by mTORC1 inhibition in cervical cancer-derived cell lines
- Protein Interaction Network for Identifying Vascular Response of Metformin (Oral Antidiabetic)
- Preventing Long COVID With Metformin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.